ROIV Competitors & Alternatives
Compare Roivant Sciences Ltd with similar stocks in the same industry
Biotechnology
ROIV
Main Stock$35.50
Tradestie Score
50
Market Cap
$10.76B
Revenue Growth
-0.3%
Analyst Upside
+35.4%
Top Competitors
228 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
ONC
BeOne Medicines Ltd. American Depositary Shares
|
$358.77
|
$36.81B | 65.5 | 52 | Compare |
|
INSM
Insmed, Inc.
|
$108.59
|
$31.13B | - | 58 | Compare |
|
BNTX
BioNTech SE American Depositary Share
|
$96.85
|
$24.57B | - | 54 | Compare |
|
GMAB
Genmab A/S ADS
|
$34.55
|
$19.56B | 28.1 | 42 | Compare |
|
INCY
Incyte Genomics Inc
|
$117.14
|
$16.93B | 15.2 | 55 | Compare |
|
RPRX
Royalty Pharma plc Class A Ordinary Shares
|
$57.63
|
$15.70B | 31.4 | 66 | Compare |
|
SMMT
Summit Therapeutics Inc. Common Stock
|
$16.69
|
$15.22B | - | 49 | Compare |
|
ASND
Ascendis Pharma A/S American Depositary Shares
|
$227.31
|
$12.36B | 17.9 | 69 | Compare |
|
EXEL
Exelixis Inc
|
$57.94
|
$11.09B | 18.4 | 48 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$188.94
|
$10.74B | - | 36 | Compare |
More ROIV Analysis
Data updated: Oct 01, 2026 | Industry: Biotechnology (SIC 2834)
228 stocks in this industry